PALVELLA THERAPEUTICS, INC. (PVLA)

Latest Insider Confidence Score

2026Q1

49.5
Bearish

Company insider confidence (by quarter)

2015Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Aquilo Capital Management, LLC 10% Owner 3,675,530 Jul 22, 2020
Bvf Partners L P/Il 10% Owner 204,301 Dec 17, 2024
Biotechnology Value Fund L P Other 204,301 Dec 17, 2024
Bvf I Gp Llc 204,301 Dec 17, 2024
Biotechnology Value Fund II Lp Other 204,301 Dec 17, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Mar 2, 2026 JENKINS GEORGE M Director Buy 85.0 +4,000 2.03% $500K
Feb 27, 2026 Mar 2, 2026 HERON ELAINE J Director Buy 90.0 +2,400 4.68% $300K
Feb 18, 2026 Feb 20, 2026 Goin Kathleen COO Sell 10.0 -4,302 -100.00% $341.6K
Feb 5, 2026 Feb 9, 2026 Martini Jeffrey S Chief Scientific Officer Neutral 52.5 - 0.00% -
Feb 5, 2026 Feb 9, 2026 Kline Ashley Hartmann Chief Commercial Officer Neutral 52.5 - 0.00% -
Feb 5, 2026 Feb 9, 2026 Kaupinen Wes CEO Neutral 52.5 - 0.00% -
Feb 5, 2026 Feb 9, 2026 Korenberg Matthew E CFO Neutral 52.5 - 0.00% -
Feb 5, 2026 Feb 9, 2026 Goin Kathleen COO Neutral 52.5 - 0.00% -
Jan 21, 2026 Jan 23, 2026 Goin Kathleen COO Sell 10.0 -4,302 -100.00% $420K
Dec 17, 2025 Dec 19, 2025 Goin Kathleen COO Sell 7.5 -4,302 -100.00% $415K
Nov 19, 2025 Nov 21, 2025 Goin Kathleen COO Sell 7.5 -4,302 -100.00% $371K
Jun 10, 2025 Jun 11, 2025 Wessel Tadd S. Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 KIRITSY CHRISTOPHER P Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 JENKINS GEORGE M Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 HERON ELAINE J Director Neutral 52.5 - 0.00% -
Jun 10, 2025 Jun 11, 2025 Davis Todd C Director Neutral 52.5 - 0.00% -
May 27, 2025 Jun 3, 2025 Kline Ashley Hartmann Chief Commercial Officer Neutral 52.5 - 0.00% -
Jun 3, 2025 Kline Ashley Hartmann Chief Commercial Officer Neutral 52.5 - 0.00% -
Apr 9, 2025 Apr 10, 2025 JENKINS GEORGE M Director Buy 87.5 +4,990 2.60% $100.8K
Feb 5, 2025 Feb 10, 2025 Kaupinen Wes CEO Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 10, 2025 Martini Jeffrey S Chief Scientific Officer Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 10, 2025 Goin Kathleen COO Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 10, 2025 Korenberg Matthew E CFO Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 7, 2025 PALVELLA THERAPEUTICS, INC. Chief Scientific Officer Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 7, 2025 PALVELLA THERAPEUTICS, INC. CFO Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 7, 2025 PALVELLA THERAPEUTICS, INC. CEO Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 7, 2025 PALVELLA THERAPEUTICS, INC. COO Neutral 52.5 - 0.00% -
Jan 6, 2025 Kaupinen Wes CEO Neutral 52.5 - 0.00% -
Dec 18, 2024 Dec 19, 2024 JENKINS GEORGE M Director Buy 82.5 +4,000 2.13% $51.7K
Dec 13, 2024 Dec 17, 2024 HERON ELAINE J Director Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 Wessel Tadd S. Director Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 Davis Todd C Director Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 Martini Jeffrey S Chief Scientific Officer Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 Goin Kathleen COO Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 Korenberg Matthew E CFO Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 JENKINS GEORGE M Director Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 Kaupinen Wes CEO Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 KIRITSY CHRISTOPHER P Director Neutral 52.5 - 0.00% -
Dec 13, 2024 Dec 17, 2024 BVF PARTNERS L P/IL Other Neutral 90.0 +438,929 172.69% -
Dec 16, 2024 Korenberg Matthew E CFO Neutral 52.5 - 0.00% -
Dec 16, 2024 Wessel Tadd S. Director Neutral 52.5 - 0.00% -
Dec 16, 2024 Kaupinen Wes CEO Neutral 52.5 - 0.00% -
Dec 16, 2024 Goin Kathleen COO Neutral 52.5 - 0.00% -
Dec 16, 2024 Martini Jeffrey S Chief Scientific Officer Neutral 52.5 - 0.00% -
Dec 16, 2024 JENKINS GEORGE M Director Neutral 52.5 - 0.00% -
Dec 16, 2024 Davis Todd C Director Neutral 52.5 - 0.00% -
Dec 16, 2024 HERON ELAINE J Director Neutral 52.5 - 0.00% -
Dec 16, 2024 Dellora Investments LP Other Neutral 52.5 - 0.00% -
Dec 12, 2024 Dec 12, 2024 GERAGHTY JAMES A Director Sell 27.5 -1 -100.00% $0
Dec 2, 2024 Dec 9, 2024 KIRITSY CHRISTOPHER P Director Neutral 52.5 - 0.00% -
Nov 18, 2024 Dellora Investments LP 10% Owner Neutral 52.5 - 0.00% -
Aug 7, 2024 Oct 28, 2024 GERAGHTY JAMES A Director Buy 90.0 +1 100.00% $1
Aug 9, 2024 Aug 12, 2024 ADAR1 Capital Management, LLC 10% Owner Buy 87.5 +6,000 4.33% $92.3K
Jul 31, 2024 ADAR1 Capital Management, LLC 10% Owner Neutral 52.5 - 0.00% -
Jun 21, 2023 Jun 23, 2023 Barbier Ann Director Neutral 52.5 - 0.00% -
Jun 21, 2023 Jun 23, 2023 GERAGHTY JAMES A Director Neutral 52.5 - 0.00% -
Jun 21, 2023 Jun 23, 2023 Kiener Peter A Director Neutral 52.5 - 0.00% -
Jun 21, 2023 Jun 23, 2023 KIRITSY CHRISTOPHER P Director Neutral 52.5 - 0.00% -
Jun 21, 2023 Jun 23, 2023 Richman Michael Director Neutral 52.5 - 0.00% -
Jun 21, 2023 Jun 23, 2023 Said Maya R. Director Neutral 52.5 - 0.00% -
Jun 21, 2023 Jun 23, 2023 Sherman Matthew L Director Neutral 52.5 - 0.00% -
May 25, 2023 May 30, 2023 KIRITSY CHRISTOPHER P Director Buy 90.0 +10,000 100.00% $8.5K
May 22, 2023 BVF PARTNERS L P/IL 10% Owner Neutral 52.5 - 0.00% -
Feb 24, 2023 Feb 28, 2023 Bures Thomas CFO Neutral 52.5 - 0.00% -
Feb 24, 2023 Feb 28, 2023 Kaufmann Hitto Chief Scientific Officer Neutral 52.5 - 0.00% -
Feb 24, 2023 Feb 28, 2023 Mousa Ahmed Chief Business Officer Neutral 52.5 - 0.00% -
Feb 24, 2023 Feb 28, 2023 Olwill Shane Chief Development Officer Neutral 52.5 - 0.00% -
Feb 24, 2023 Feb 28, 2023 Yoder Stephen S. CEO Neutral 52.5 - 0.00% -
Jun 22, 2022 Jun 24, 2022 Barbier Ann Director Neutral 52.5 - 0.00% -
Jun 22, 2022 Jun 24, 2022 Said Maya R. Director Neutral 52.5 - 0.00% -
Jun 22, 2022 Jun 24, 2022 GERAGHTY JAMES A Director Neutral 52.5 - 0.00% -
Jun 22, 2022 Jun 24, 2022 Kiener Peter A Director Neutral 52.5 - 0.00% -
Jun 22, 2022 Jun 24, 2022 KIRITSY CHRISTOPHER P Director Neutral 52.5 - 0.00% -
Jun 22, 2022 Jun 24, 2022 Richman Michael Director Neutral 52.5 - 0.00% -
Jun 22, 2022 Jun 24, 2022 Sherman Matthew L Director Neutral 52.5 - 0.00% -
May 13, 2022 May 16, 2022 Demuth Tim Chief Medical Officer Buy 91.3 +6,000 100.00% $10.3K
Feb 22, 2022 Feb 24, 2022 Demuth Tim Chief Medical Officer Neutral 52.5 - 0.00% -
Feb 22, 2022 Feb 24, 2022 Mousa Ahmed Chief Business Officer Neutral 52.5 - 0.00% -
Feb 22, 2022 Feb 24, 2022 Olwill Shane Chief Development Officer Neutral 52.5 - 0.00% -
Feb 22, 2022 Feb 24, 2022 Bures Thomas CFO Neutral 52.5 - 0.00% -
Feb 22, 2022 Feb 24, 2022 Kaufmann Hitto SVP, Chief Scientific Officer Neutral 52.5 - 0.00% -
Feb 22, 2022 Feb 24, 2022 Yoder Stephen S. CEO Neutral 52.5 - 0.00% -
Oct 21, 2021 Mousa Ahmed Chief Business Officer Neutral 52.5 - 0.00% -
Aug 30, 2021 Sep 1, 2021 Olwill Shane Chief Development Officer Sell 22.5 -38,400 -89.22% $196.4K
Aug 1, 2021 Aug 3, 2021 Demuth Tim Chief Medical Officer Neutral 52.5 - 0.00% -
Aug 3, 2021 Demuth Tim Chief Medical Officer Neutral 52.5 - 0.00% -
Aug 3, 2021 Olwill Shane Chief Development Officer Neutral 52.5 - 0.00% -
Jun 25, 2021 Jun 29, 2021 Sherman Matthew L Director Neutral 52.5 - 0.00% -
Jun 25, 2021 Jun 29, 2021 Said Maya R. Director Neutral 52.5 - 0.00% -
Jun 25, 2021 Jun 29, 2021 Richman Michael Director Neutral 52.5 - 0.00% -
Jun 25, 2021 Jun 29, 2021 KIRITSY CHRISTOPHER P Director Neutral 52.5 - 0.00% -
Jun 25, 2021 Jun 29, 2021 Kiener Peter A Director Neutral 52.5 - 0.00% -
Jun 25, 2021 Jun 29, 2021 GERAGHTY JAMES A Director Neutral 52.5 - 0.00% -
Jun 25, 2021 Jun 29, 2021 Barbier Ann Director Neutral 52.5 - 0.00% -
Mar 4, 2021 Mar 8, 2021 Bures Thomas President Neutral 52.5 - 0.00% -
Mar 4, 2021 Mar 8, 2021 Kaufmann Hitto SVP, Chief Scientific Officer Neutral 52.5 - 0.00% -
Mar 4, 2021 Mar 8, 2021 Yoder Stephen S. CEO Neutral 52.5 - 0.00% -
Jul 21, 2020 Jul 22, 2020 Aquilo Capital Management, LLC 10% Owner Sell 16.3 -1,900,000 -34.08% $5.6M
Jun 23, 2020 Jun 25, 2020 KIRITSY CHRISTOPHER P Director Neutral 52.5 - 0.00% -
Jun 23, 2020 Jun 25, 2020 Said Maya R. Director Neutral 52.5 - 0.00% -